The role of C-reactive protein in prostate cancer

Authors

  • Julie N. Graff MD,

    1. Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon
    Search for more papers by this author
  • Tomasz M. Beer MD

    Corresponding author
    1. Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon
    • Corresponding author: Tomasz M. Beer, MD, OHSU Knight Cancer Institute, 3303 SW Bond Avenue, CH14R, Portland, OR 97239. Fax: (503) 494-6197; E-mail: beert@ohsu.edu.

    Search for more papers by this author

  • See referenced original article on pages 3272-3279, this issue.

Abstract

In retrospective analyses, elevated C-reactive protein indicates a poor prognosis in prostate cancer patients. We review what is known about the role of C-reactive protein in prostate cancer and describe circumstances in which it may be helpful.

Ancillary